On the other hand, visfatin/Nampt may contribute to exacerbated angiogenesis leading to ischemic heart disease, diabetes, or atherosclerosis and may therefore arise as a novel pharmacological target for treating such conditions. The gene discussed is NAMPT; the disease is atherosclerosis.